Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of structured training in osteotomy and splitting for BSSO using a 3D-printed mandibular model.

BMC medical education·2026
Same author

KlimaNot-Effects of Climate Change on Emergency and Acute Care: Protocol for a Multicenter, Registry-Based Observational Cohort Study.

JMIR research protocols·2026
Same author

Selective vulnerability of dopaminergic neurons in Parkinson's disease connects PRKN and differential expression of CHCHD2 and GPNMB.

Cell death & disease·2026
Same author

Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset.

NPJ Parkinson's disease·2026
Same author

Extending Interoperable Emergency Department Data: Standards-Based Design and Evaluation in AKTIN.

Studies in health technology and informatics·2026
Same author

From Fragmentation to Transparency: Exploring and Mapping the Landscape of Medical Registries in Germany.

Studies in health technology and informatics·2026

Related Experiment Video

Updated: May 14, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Flexible Data Integration for Genomics-Driven Decision Support in Rare Genetic Epilepsy.

Ariadna Pérez Garriga1, Philipp Honrath2, Stefan Wolking2

  • 1Institute of Medical Informatics, Medical Faculty, RWTH Aachen University, Aachen, Germany.

Studies in Health Technology and Informatics
|May 12, 2026
PubMed
Summary

A flexible EAV-hybrid model efficiently organizes diverse clinical and genomic data for precision medicine in genetic epilepsy. This approach supports early-stage research and clinical decision-making.

Keywords:
Common Data ModelData ManagementData StandardizationEpilepsyPrecision Medicine

More Related Videos

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Related Experiment Videos

Last Updated: May 14, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Area of Science:

  • Biomedical Informatics
  • Genomics
  • Precision Medicine

Background:

  • Integrating heterogeneous clinical and genomic data is crucial for precision medicine in complex diseases like epilepsy.
  • Interpreting numerous disease-associated genes presents a significant challenge.

Purpose of the Study:

  • To develop an efficient and flexible data organization system for precision medicine in genetic epilepsy projects.
  • To address the challenges of integrating disparate biomedical data sources in early project stages.

Main Methods:

  • A three-step system design approach tailored for academic medical research was employed.
  • Considerations included project requirements, available resources, and technology selection.
  • An EAV-hybrid model was developed for data accommodation.

Main Results:

  • The EAV-hybrid model successfully integrated diverse clinical and genetic data, maintaining flexibility for future expansion.
  • Integration with cBioPortal facilitated intuitive data visualization and interpretation.
  • The system design supports future migration to standard common data models (CDMs) like OMOP or i2b2.

Conclusions:

  • A flexible, metadata-driven EAV-hybrid model enables rapid prototyping and structured data integration in early-stage precision medicine projects.
  • This infrastructure supports molecular boards and clinical decision-making for genetic epilepsies.
  • The model provides a scalable solution for managing complex biomedical data.